Sangamo Therapeutics
SGMO
#6406
Rank
A$0.88 B
Marketcap
$4.23
Share price
13.77%
Change (1 day)
547.84%
Change (1 year)

Revenue for Sangamo Therapeutics (SGMO)

Revenue in 2024 (TTM): A$18.88 Million

According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM ) is A$18.48 Million. In 2023 the company made a revenue of A$0.25 Billion an increase over the revenue in the year 2022 that were of A$0.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sangamo Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$18.88 M-92.7%
2023 A$0.25 B58.16%
2022 A$0.16 B7.11%
2021 A$0.15 B-0.66%
2020 A$0.15 B5.07%
2019 A$0.14 B22.04%
2018 A$0.11 B155.94%
2017 A$46.83 M74.13%
2016 A$26.89 M-50.44%
2015 A$54.27 M-3.16%
2014 A$56.04 M107.16%
2013 A$27.05 M29.84%
2012 A$20.83 M107.06%
2011 A$10.06 M-50.86%
2010 A$20.48 M-17.07%
2009 A$24.69 M7.66%
2008 A$22.94 M120.46%
2007 A$10.4 M4.04%
2006 A$10 M194.76%
2005 A$3.39 M99.7%
2004 A$1.69 M-51.02%
2003 A$3.46 M-54.99%
2002 A$7.7 M-19.47%
2001 A$9.57 M55.89%
2000 A$6.14 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$41.86 B 226,364.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.15 B 16,962.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$48.99 B 264,899.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.56 B 78,681.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$65.02 B 351,614.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$132.06 B 714,211.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.14 B 22,322.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$94.08 B 508,810.97%๐Ÿ‡บ๐Ÿ‡ธ USA